<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no">
<title>Pharmacokinetics & dynamic , AD, clinical trial</title>
<link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.1/css/all.min.css" rel="stylesheet">
<link href="https://fonts.googleapis.com/css2?family=Poppins:wght@300;400;500;600;700;800&display=swap" rel="stylesheet">
<style>
*{margin:0;padding:0;box-sizing:border-box;-webkit-tap-highlight-color:transparent}
:root{--primary:#667eea;--primary-dark:#5568d3;--secondary:#764ba2;--success:#48bb78;--danger:#f5576c;--warning:#fbbf24;--info:#4facfe;--bg-light:#f7fafc;--bg-white:#fff;--text-dark:#1a202c;--text-light:#718096;--border:#e2e8f0}
[data-theme="dark"]{--bg-light:#1a202c;--bg-white:#2d3748;--text-dark:#f7fafc;--text-light:#cbd5e0;--border:#4a5568}
body{font-family:'Poppins',-apple-system,BlinkMacSystemFont,sans-serif;background:linear-gradient(135deg,var(--primary) 0%,var(--secondary) 100%);min-height:100vh;overflow:hidden;user-select:none;-webkit-user-select:none;transition:background .3s}
.scrollable::-webkit-scrollbar{width:6px}
.scrollable::-webkit-scrollbar-track{background:transparent}
.scrollable::-webkit-scrollbar-thumb{background:var(--primary);border-radius:10px}
.protected-content{white-space:pre-wrap;word-wrap:break-word;word-break:break-word;line-height:1.6;user-select:none}
#modeSelection{position:fixed;top:0;left:0;width:100%;height:100%;background:linear-gradient(135deg,#667eea 0%,#764ba2 100%);display:flex;align-items:center;justify-content:center;z-index:9999;padding:20px;overflow-y:auto}
.mode-container{background:#fff;border-radius:24px;padding:40px 30px;max-width:500px;width:100%;box-shadow:0 20px 60px rgba(0,0,0,.3);animation:ms .5s cubic-bezier(.34,1.56,.64,1)}
@keyframes ms{from{opacity:0;transform:translateY(40px) scale(.95)}to{opacity:1;transform:translateY(0) scale(1)}}
.mode-header{text-align:center;margin-bottom:32px}
.mode-header-icon{width:70px;height:70px;margin:0 auto 16px;background:linear-gradient(135deg,#667eea 0%,#764ba2 100%);border-radius:20px;display:flex;align-items:center;justify-content:center;font-size:36px;color:#fff;box-shadow:0 8px 24px rgba(102,126,234,.3)}
.mode-header h2{font-size:24px;font-weight:700;color:#1a202c;margin-bottom:8px}
.mode-header p{font-size:14px;color:#718096;font-weight:400}
.mode-cards{display:grid;gap:16px;margin-bottom:24px}
.mode-card{background:#f7fafc;border:2px solid #e2e8f0;border-radius:16px;padding:20px;cursor:pointer;transition:all .3s;position:relative}
.mode-card:hover{transform:translateY(-3px);box-shadow:0 12px 28px rgba(102,126,234,.15);border-color:#cbd5e0}
.mode-card.selected{border-color:#667eea;background:#fff;box-shadow:0 8px 24px rgba(102,126,234,.2);transform:translateY(-2px)}
.mode-card-header{display:flex;align-items:center}
.mode-icon{width:54px;height:54px;border-radius:14px;display:flex;align-items:center;justify-content:center;font-size:24px;margin-right:16px;flex-shrink:0}
.exam-mode .mode-icon{background:linear-gradient(135deg,#f093fb 0%,#f5576c 100%);color:#fff}
.practice-mode .mode-icon{background:linear-gradient(135deg,#4facfe 0%,#00f2fe 100%);color:#fff}
.mode-info h3{font-size:17px;font-weight:700;color:#1a202c;margin-bottom:4px}
.mode-info p{font-size:13px;color:#718096;line-height:1.4}
.timer-config{margin-bottom:24px}
.timer-config label{display:block;font-size:14px;font-weight:600;color:#1a202c;margin-bottom:10px}
.timer-config label i{margin-right:6px;color:#667eea}
.timer-input{width:100%;padding:14px 16px;border:2px solid #e2e8f0;border-radius:12px;font-size:15px;font-weight:500;transition:all .3s;background:#fff;font-family:'Poppins',sans-serif;color:#1a202c}
.timer-input::placeholder{color:#a0aec0}
.timer-input:focus{outline:none;border-color:#667eea;box-shadow:0 0 0 3px rgba(102,126,234,.1)}
.start-btn{width:100%;padding:16px;background:linear-gradient(135deg,#667eea 0%,#764ba2 100%);color:#fff;border:none;border-radius:14px;font-size:16px;font-weight:700;cursor:pointer;transition:all .3s;display:flex;align-items:center;justify-content:center;gap:10px;box-shadow:0 8px 20px rgba(102,126,234,.35)}
.start-btn:hover:not(:disabled){transform:translateY(-2px);box-shadow:0 12px 28px rgba(102,126,234,.45)}
.start-btn:active:not(:disabled){transform:translateY(0)}
.start-btn:disabled{opacity:.5;cursor:not-allowed;background:#cbd5e0;box-shadow:none}
#quizContainer{display:none;position:fixed;top:0;left:0;width:100%;height:100vh;background:var(--bg-light);overflow:hidden}
.quiz-header{position:fixed;top:0;left:0;right:0;background:var(--bg-white);box-shadow:0 2px 15px rgba(0,0,0,.08);z-index:100;padding:16px 20px}
.header-top{display:flex;justify-content:space-between;align-items:center;margin-bottom:12px;gap:10px}
.quiz-title{font-size:15px;font-weight:700;color:var(--text-dark);display:flex;align-items:center;gap:8px;flex:1;min-width:0}
.quiz-title-text{overflow:hidden;text-overflow:ellipsis;white-space:nowrap;max-width:150px}
.mode-badge{font-size:10px;padding:4px 10px;border-radius:20px;font-weight:700;text-transform:uppercase;letter-spacing:.5px;white-space:nowrap}
.mode-badge.exam{background:linear-gradient(135deg,#f093fb 0%,#f5576c 100%);color:#fff}
.mode-badge.practice{background:linear-gradient(135deg,#4facfe 0%,#00f2fe 100%);color:#fff}
.header-actions{display:flex;gap:8px;align-items:center}
.theme-toggle{width:36px;height:36px;background:var(--bg-light);border:none;border-radius:10px;cursor:pointer;display:flex;align-items:center;justify-content:center;font-size:16px;color:var(--text-dark);transition:all .3s}
.theme-toggle:hover{transform:scale(1.1)}
.timer-display{display:flex;align-items:center;gap:8px;font-size:16px;font-weight:700;color:var(--primary);padding:8px 14px;background:linear-gradient(135deg,rgba(102,126,234,.15) 0%,rgba(118,75,162,.15) 100%);border-radius:12px;white-space:nowrap}
.timer-display.warning{color:var(--danger);background:linear-gradient(135deg,rgba(245,87,108,.15) 0%,rgba(240,147,251,.15) 100%);animation:pulse 1s infinite}
@keyframes pulse{0%,100%{opacity:1}50%{opacity:.7}}
.header-progress{display:flex;justify-content:space-between;align-items:center;font-size:12px;color:var(--text-light);margin-bottom:8px}
.progress-bar-container{height:6px;background:var(--border);border-radius:10px;overflow:hidden}
.progress-bar{height:100%;background:linear-gradient(90deg,var(--primary) 0%,var(--secondary) 100%);transition:width .3s;border-radius:10px}
.question-section{position:fixed;top:140px;left:0;right:0;bottom:80px;overflow-y:auto;overflow-x:hidden;padding:20px;-webkit-overflow-scrolling:touch}
.question-section.scrollable{scrollbar-width:thin;scrollbar-color:var(--primary) transparent}
.question-card{background:var(--bg-white);border-radius:20px;padding:24px;box-shadow:0 4px 20px rgba(0,0,0,.06);max-width:800px;margin:0 auto}
.question-number{display:inline-flex;align-items:center;gap:8px;font-size:13px;font-weight:700;color:var(--primary);background:linear-gradient(135deg,rgba(102,126,234,.15) 0%,rgba(118,75,162,.15) 100%);padding:6px 14px;border-radius:20px;margin-bottom:16px}
.question-reference{background:linear-gradient(135deg,rgba(79,172,254,.15) 0%,rgba(0,242,254,.15) 100%);border-left:4px solid var(--info);padding:14px 16px;border-radius:10px;margin-bottom:16px;font-size:14px;color:var(--text-dark);line-height:1.6;white-space:pre-wrap;word-wrap:break-word}
.question-text{font-size:16px;font-weight:600;color:var(--text-dark);line-height:1.7;margin-bottom:20px;white-space:pre-wrap;word-wrap:break-word;word-break:break-word}
.options-container{display:grid;gap:12px}
.option-btn{width:100%;padding:16px 18px;background:var(--bg-light);border:3px solid var(--border);border-radius:14px;text-align:left;font-size:15px;color:var(--text-dark);cursor:pointer;transition:all .3s;display:flex;align-items:flex-start;gap:12px;line-height:1.6;white-space:pre-wrap;word-wrap:break-word;word-break:break-word;user-select:none}
.option-btn:active{transform:scale(.98)}
.option-indicator{min-width:28px;height:28px;border-radius:50%;background:var(--bg-white);border:2px solid var(--border);display:flex;align-items:center;justify-content:center;font-size:13px;font-weight:600;transition:all .3s}
.option-text{flex:1;padding-top:3px}
.option-btn:hover:not(.disabled){border-color:var(--primary);transform:translateX(4px)}
.option-btn.selected{background:linear-gradient(135deg,rgba(102,126,234,.15) 0%,rgba(118,75,162,.15) 100%);border-color:var(--primary)}
.option-btn.selected .option-indicator{background:linear-gradient(135deg,var(--primary) 0%,var(--secondary) 100%);color:#fff;border-color:transparent}
.option-btn.correct{background:linear-gradient(135deg,rgba(72,187,120,.15) 0%,rgba(72,187,120,.15) 100%);border-color:var(--success)}
.option-btn.correct .option-indicator{background:var(--success);color:#fff;border-color:transparent}
.option-btn.incorrect{background:linear-gradient(135deg,rgba(245,87,108,.15) 0%,rgba(245,87,108,.15) 100%);border-color:var(--danger)}
.option-btn.incorrect .option-indicator{background:var(--danger);color:#fff;border-color:transparent}
.option-btn.disabled{pointer-events:none;opacity:.6}
.explanation-box{display:none;background:linear-gradient(135deg,rgba(254,245,231,.5) 0%,rgba(251,191,36,.2) 100%);border-left:4px solid var(--warning);border-radius:12px;padding:16px;margin-top:20px;animation:sd .3s ease-out}
@keyframes sd{from{opacity:0;max-height:0;padding:0}to{opacity:1;max-height:500px;padding:16px}}
.explanation-header{display:flex;align-items:center;gap:8px;font-size:14px;font-weight:700;color:#92400e;margin-bottom:10px}
.explanation-text{font-size:14px;color:#78350f;line-height:1.6;white-space:pre-wrap;word-wrap:break-word}
[data-theme="dark"] .explanation-text{color:#fbbf24}
.nav-controls{position:fixed;bottom:0;left:0;right:0;background:var(--bg-white);padding:16px 20px;box-shadow:0 -2px 15px rgba(0,0,0,.08);display:flex;gap:12px;z-index:90}
.nav-btn{flex:1;padding:14px;border:none;border-radius:12px;font-size:15px;font-weight:600;cursor:pointer;transition:all .3s;display:flex;align-items:center;justify-content:center;gap:8px}
.nav-btn.primary{background:linear-gradient(135deg,var(--primary) 0%,var(--secondary) 100%);color:#fff}
.nav-btn.secondary{background:var(--bg-light);color:var(--text-dark);border:2px solid var(--border)}
.nav-btn:active{transform:scale(.96)}
.nav-btn:disabled{opacity:.5;cursor:not-allowed;transform:none}
.question-nav-toggle{position:fixed;bottom:100px;right:20px;width:56px;height:56px;background:linear-gradient(135deg,var(--primary) 0%,var(--secondary) 100%);color:#fff;border:none;border-radius:50%;font-size:22px;cursor:pointer;box-shadow:0 8px 20px rgba(102,126,234,.4);z-index:85;transition:all .3s}
.question-nav-toggle:active{transform:scale(.95)}
.question-nav-panel{position:fixed;bottom:0;left:0;right:0;background:var(--bg-white);border-radius:24px 24px 0 0;box-shadow:0 -4px 30px rgba(0,0,0,.15);z-index:95;max-height:70vh;overflow-y:auto;transform:translateY(100%);transition:transform .3s;padding:20px}
.question-nav-panel.open{transform:translateY(0)}
.nav-panel-header{display:flex;justify-content:space-between;align-items:center;margin-bottom:20px;padding-bottom:16px;border-bottom:2px solid var(--border)}
.nav-panel-title{font-size:18px;font-weight:700;color:var(--text-dark)}
.nav-close-btn{width:32px;height:32px;background:var(--bg-light);border:none;border-radius:50%;font-size:16px;cursor:pointer;color:var(--text-light)}
.nav-legend{display:flex;flex-wrap:wrap;gap:12px;margin-bottom:20px;font-size:12px;color:var(--text-dark)}
.legend-item{display:flex;align-items:center;gap:6px;color:var(--text-dark)}
.legend-box{width:20px;height:20px;border-radius:6px}
.legend-box.answered{background:linear-gradient(135deg,var(--primary) 0%,var(--secondary) 100%)}
.legend-box.marked{background:linear-gradient(135deg,var(--warning) 0%,#f59e0b 100%)}
.legend-box.unanswered{background:var(--border)}
.question-grid{display:grid;grid-template-columns:repeat(5,1fr);gap:10px}
.question-nav-item{aspect-ratio:1;border:2px solid var(--border);border-radius:10px;background:var(--bg-white);display:flex;align-items:center;justify-content:center;font-size:15px;font-weight:600;cursor:pointer;transition:all .3s;color:var(--text-light)}
.question-nav-item:active{transform:scale(.95)}
.question-nav-item.current{border-color:var(--primary);background:linear-gradient(135deg,rgba(102,126,234,.15) 0%,rgba(118,75,162,.15) 100%);color:var(--primary)}
.question-nav-item.answered{background:linear-gradient(135deg,var(--primary) 0%,var(--secondary) 100%);color:#fff;border-color:transparent}
.question-nav-item.marked{background:linear-gradient(135deg,var(--warning) 0%,#f59e0b 100%);color:#fff;border-color:transparent}
.question-nav-item.correct{background:linear-gradient(135deg,var(--success) 0%,#38a169 100%);color:#fff;border-color:transparent}
.question-nav-item.incorrect{background:linear-gradient(135deg,var(--danger) 0%,#e53e3e 100%);color:#fff;border-color:transparent}
#resultsContainer{display:none;position:fixed;top:0;left:0;width:100%;height:100vh;background:var(--bg-light);overflow-y:auto;overflow-x:hidden;padding:20px;z-index:1000}
#resultsContainer.scrollable{scrollbar-width:thin;scrollbar-color:var(--primary) transparent}
.results-header{text-align:center;padding:40px 20px;background:var(--bg-white);border-radius:20px;margin-bottom:20px;box-shadow:0 4px 20px rgba(0,0,0,.06)}
.results-icon{font-size:80px;margin-bottom:20px}
.results-title{font-size:28px;font-weight:700;color:var(--text-dark);margin-bottom:10px}
.results-score{font-size:52px;font-weight:800;background:linear-gradient(135deg,var(--primary) 0%,var(--secondary) 100%);-webkit-background-clip:text;-webkit-text-fill-color:transparent;background-clip:text;margin-bottom:10px}
.results-percentage{font-size:20px;color:var(--text-light);font-weight:600}
.stats-grid{display:grid;grid-template-columns:repeat(2,1fr);gap:12px;margin-bottom:20px;max-width:800px;margin-left:auto;margin-right:auto}
.stat-card{background:var(--bg-white);padding:24px;border-radius:16px;box-shadow:0 4px 20px rgba(0,0,0,.06)}
.stat-icon{width:44px;height:44px;border-radius:12px;display:flex;align-items:center;justify-content:center;font-size:20px;margin-bottom:12px}
.stat-icon.correct{background:linear-gradient(135deg,var(--success) 0%,#38a169 100%);color:#fff}
.stat-icon.incorrect{background:linear-gradient(135deg,var(--danger) 0%,#e53e3e 100%);color:#fff}
.stat-icon.unattempted{background:linear-gradient(135deg,#a0aec0 0%,#718096 100%);color:#fff}
.stat-icon.negative{background:linear-gradient(135deg,#ed8936 0%,#dd6b20 100%);color:#fff}
.stat-value{font-size:32px;font-weight:700;color:var(--text-dark);margin-bottom:4px}
.stat-label{font-size:13px;color:var(--text-light);font-weight:500}
.action-buttons{display:grid;gap:12px;max-width:800px;margin:0 auto}
.action-btn{width:100%;padding:18px;border:none;border-radius:12px;font-size:16px;font-weight:600;cursor:pointer;display:flex;align-items:center;justify-content:center;gap:10px;transition:all .3s}
.action-btn.primary{background:linear-gradient(135deg,var(--primary) 0%,var(--secondary) 100%);color:#fff}
.action-btn.secondary{background:var(--bg-white);color:var(--text-dark);border:2px solid var(--border)}
.action-btn:hover{transform:translateY(-2px)}

    @media (min-width: 1024px) {
        body { overflow: auto !important; }
        
        #quizContainer {
            display: grid !important;
            grid-template-columns: 1fr 320px;
            grid-template-rows: auto 1fr auto;
            gap: 0;
            height: 100vh;
            overflow: hidden;
        }
        
        .quiz-header {
            grid-column: 1 / -1;
            position: static;
            padding: 20px 32px;
            border-bottom: 3px solid var(--border);
        }
        
        .header-top {
            max-width: none;
            margin-bottom: 16px;
        }
        
        .quiz-title-text { max-width: 400px; }
        
        .timer-display {
            padding: 10px 20px;
            font-size: 18px;
        }
        
        /* Main content area - scrollable */
        .question-section {
            position: static !important;
            grid-column: 1;
            grid-row: 2;
            overflow-y: auto;
            padding: 32px;
            background: var(--bg-light);
            top: auto !important;
            bottom: auto !important;
        }
        
        .question-card {
            max-width: 900px;
            padding: 32px;
            margin: 0 auto 24px;
        }
        
        .question-text {
            font-size: 18px;
            margin-bottom: 24px;
        }
        
        .option-btn {
            padding: 18px 20px;
            font-size: 16px;
        }
        
        .option-indicator {
            min-width: 32px;
            height: 32px;
            font-size: 14px;
        }
        
        /* Desktop Question Navigator - Right Panel */
        .question-nav-panel {
            position: static !important;
            grid-column: 2;
            grid-row: 2;
            transform: none !important;
            max-height: none;
            height: 100%;
            border-radius: 0;
            border-left: 3px solid var(--border);
            box-shadow: none;
            padding: 24px;
            overflow-y: auto;
            background: var(--bg-white);
        }
        
        .question-nav-panel.open { transform: none !important; }
        
        .nav-panel-header {
            position: sticky;
            top: 0;
            background: var(--bg-white);
            z-index: 10;
            padding-bottom: 20px;
            margin-bottom: 20px;
        }
        
        .nav-panel-title {
            font-size: 16px;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }
        
        .nav-close-btn { display: none; }
        
        .nav-legend {
            position: sticky;
            top: 60px;
            background: var(--bg-white);
            z-index: 9;
            padding: 16px;
            margin: -16px -16px 20px;
            border-radius: 12px;
            background: var(--bg-light);
        }
        
        .question-grid {
            grid-template-columns: repeat(4, 1fr);
            gap: 12px;
        }
        
        .question-nav-item {
            aspect-ratio: 1;
            font-size: 16px;
            border-radius: 12px;
        }
        
        .question-nav-toggle { display: none; }
        
        /* Footer Navigation - Sticky */
        .nav-controls {
            position: static;
            grid-column: 1;
            grid-row: 3;
            padding: 20px 32px;
            border-top: 3px solid var(--border);
            max-width: none;
            display: flex;
            justify-content: center;
            gap: 16px;
        }
        
        .nav-btn {
            min-width: 160px;
            padding: 16px 24px;
            font-size: 16px;
        }
        
        /* Results Desktop Layout */
        #resultsContainer {
            padding: 40px;
            max-width: 1400px;
            margin: 0 auto;
        }
        
        .results-header {
            padding: 60px 40px;
            margin-bottom: 32px;
        }
        
        .results-icon { font-size: 100px; }
        .results-title { font-size: 36px; }
        .results-score { font-size: 64px; }
        .results-percentage { font-size: 24px; }
        
        .stats-grid {
            grid-template-columns: repeat(4, 1fr);
            gap: 20px;
            margin-bottom: 32px;
            max-width: none;
        }
        
        .stat-card { padding: 32px; }
        .stat-icon { width: 54px; height: 54px; font-size: 24px; }
        .stat-value { font-size: 40px; }
        .stat-label { font-size: 14px; }
        
        .action-buttons {
            grid-template-columns: repeat(2, 1fr);
            gap: 20px;
            max-width: 800px;
        }
        
        .action-btn { padding: 20px; font-size: 17px; }
        
        /* Mode Selection Desktop */
        .mode-container {
            max-width: 600px;
            padding: 50px 40px;
        }
        
        .mode-header-icon {
            width: 80px;
            height: 80px;
            font-size: 40px;
        }
        
        .mode-header h2 { font-size: 28px; }
        .mode-header p { font-size: 15px; }
        
        .mode-cards { gap: 20px; }
        
        .mode-card {
            padding: 24px;
            border-radius: 18px;
        }
        
        .mode-icon {
            width: 60px;
            height: 60px;
            font-size: 28px;
            margin-right: 20px;
        }
        
        .mode-info h3 { font-size: 19px; }
        .mode-info p { font-size: 14px; }
        
        .timer-input { padding: 16px 18px; font-size: 16px; }
        .start-btn { padding: 18px; font-size: 17px; }
    }
    
    /* Ultra-wide Desktop */
    @media (min-width: 1440px) {
        #quizContainer {
            grid-template-columns: 1fr 380px;
        }
        
        .question-section { padding: 40px 60px; }
        .question-card { max-width: 1000px; padding: 40px; }
        .question-nav-panel { padding: 32px; }
        .question-grid { grid-template-columns: repeat(5, 1fr); }
        .nav-controls { padding: 24px 60px; }
    }
    
</style>
</head>
<body>
<div id="modeSelection">
<div class="mode-container">
<div class="mode-header">
<div class="mode-header-icon"><i class="fas fa-graduation-cap"></i></div>
<h2>Pharmacokinetics & dynamic , AD, clinical trial</h2>
<p>Choose your preferred test mode</p>
</div>
<div class="mode-cards">
<div class="mode-card exam-mode" data-mode="exam">
<div class="mode-card-header">
<div class="mode-icon"><i class="fas fa-file-alt"></i></div>
<div class="mode-info">
<h3>Exam Mode</h3>
<p>Complete all questions, results shown after submission</p>
</div>
</div>
</div>
<div class="mode-card practice-mode" data-mode="practice">
<div class="mode-card-header">
<div class="mode-icon"><i class="fas fa-book-open"></i></div>
<div class="mode-info">
<h3>Practice Mode</h3>
<p>Instant feedback with detailed explanations</p>
</div>
</div>
</div>
</div>
<div class="timer-config">
<label for="ct"><i class="fas fa-clock"></i> Custom Timer (minutes)</label>
<input type="number" id="ct" class="timer-input" placeholder="Default: 25 minutes" min="1" max="300"/>
</div>
<button class="start-btn" id="sb" disabled><i class="fas fa-play-circle"></i><span>Start Quiz</span></button>
</div>
</div>
<div id="quizContainer">
<div class="quiz-header">
<div class="header-top">
<div class="quiz-title">
<i class="fas fa-clipboard-list"></i>
<span class="quiz-title-text" title="Pharmacokinetics & dynamic , AD, clinical trial">Pharmacokinetics & dynamic , AD, clinical trial</span>
<span class="mode-badge" id="mb"></span>
</div>
<div class="header-actions">
<button class="theme-toggle" id="tt" title="Toggle Dark Mode"><i class="fas fa-moon"></i></button>
<div class="timer-display" id="td"><i class="fas fa-clock"></i><span id="tt2">00:00</span></div>
</div>
</div>
<div class="header-progress">
<span id="pt">Question 1 of 50</span>
<span id="at">Attempted: 0/50</span>
</div>
<div class="progress-bar-container"><div class="progress-bar" id="pb"></div></div>
</div>
<div class="question-section scrollable" id="qs"></div>
<div class="nav-controls">
<button class="nav-btn secondary" id="pv"><i class="fas fa-chevron-left"></i>Previous</button>
<button class="nav-btn secondary" id="mk"><i class="fas fa-bookmark"></i>Mark</button>
<button class="nav-btn primary" id="nx">Next<i class="fas fa-chevron-right"></i></button>
<button class="nav-btn primary" id="sm" style="display:none"><i class="fas fa-paper-plane"></i>Submit</button>
</div>
<button class="question-nav-toggle" id="nt"><i class="fas fa-th"></i></button>
<div class="question-nav-panel" id="np">
<div class="nav-panel-header">
<h3 class="nav-panel-title"><i class="fas fa-map-marked-alt"></i> Question Navigator</h3>
<button class="nav-close-btn" id="nc"><i class="fas fa-times"></i></button>
</div>
<div class="nav-legend">
<div class="legend-item"><div class="legend-box answered"></div><span>Answered</span></div>
<div class="legend-item"><div class="legend-box marked"></div><span>Marked</span></div>
<div class="legend-item"><div class="legend-box unanswered"></div><span>Not Answered</span></div>
</div>
<div class="question-grid" id="qg"></div>
</div>
</div>
<div id="resultsContainer">
<div class="results-header">
<div class="results-icon" id="ri"></div>
<h2 class="results-title" id="rt"></h2>
<div class="results-score" id="rs"></div>
<div class="results-percentage" id="rp"></div>
</div>
<div class="stats-grid">
<div class="stat-card"><div class="stat-icon correct"><i class="fas fa-check"></i></div><div class="stat-value" id="cc">0</div><div class="stat-label">Correct</div></div>
<div class="stat-card"><div class="stat-icon incorrect"><i class="fas fa-times"></i></div><div class="stat-value" id="ic">0</div><div class="stat-label">Incorrect</div></div>
<div class="stat-card"><div class="stat-icon unattempted"><i class="fas fa-minus"></i></div><div class="stat-value" id="uc">0</div><div class="stat-label">Unattempted</div></div>
<div class="stat-card"><div class="stat-icon negative"><i class="fas fa-exclamation-triangle"></i></div><div class="stat-value" id="nm">0</div><div class="stat-label">Negative Marks</div></div>
</div>
<div class="action-buttons">
<button class="action-btn primary" id="rb"><i class="fas fa-search"></i>Review Answers</button>
<button class="action-btn secondary" id="rsb"><i class="fas fa-redo"></i>Restart Quiz</button>
</div>
</div>
<script>
const qd={q:[{id:0,txt:"What is the term used to describe the study of what the body does to a drug?",ref:"",opts:["Toxicology", "Pharmacokinetics", "Pharmacodynamics", "Pharmacotherapeutics"],ci:1,exp:"Pharmacokinetics refers to the movement of drugs through the body, encompassing absorption, distribution, metabolism, and excretion (ADME)."},{id:1,txt:"Which route of administration is associated with 100% bioavailability?",ref:"",opts:["Subcutaneous", "Intravenous", "Oral", "Ex: Intravenous administration bypasses the absorption process and first-pass metabolism, ensuring the entire dose reaches systemic circulation.", "Intramuscular"],ci:1,exp:""},{id:2,txt:"The phenomenon where the concentration of a drug is greatly reduced before it reaches the systemic circulation is known as:",ref:"",opts:["Enterohepatic recycling", "First-pass metabolism", "Redistribution", "Glomerular filtration"],ci:1,exp:"First-pass effect occurs primarily in the liver or gut wall, reducing the bioavailability of orally administered drugs."},{id:3,txt:"Which of the following describes an agonist?",ref:"",opts:["A drug that binds to a receptor but produces no response", "A drug that binds to a receptor and produces a maximal biological response", "A drug that competes with the endogenous ligand", "A drug that binds to an allosteric site to inhibit the enzyme"],ci:1,exp:"An agonist has both affinity for the receptor and intrinsic activity to trigger a physiological response."},{id:4,txt:"Which phase of a clinical trial is conducted on a small number of healthy volunteers to determine safety and dosage?",ref:"",opts:["Phase IV", "Phase II", "Phase III", "Phase I"],ci:3,exp:"Phase I trials focus on safety, tolerability, and pharmacokinetics in healthy human participants."},{id:5,txt:"The \"Gray Baby Syndrome\" is a serious adverse effect associated with the use of:",ref:"",opts:["Streptomycin", "Chloramphenicol", "Penicillin", "Tetracycline"],ci:1,exp:"This occurs in neonates due to their inability to conjugate chloramphenicol because of deficient glucuronyl transferase."},{id:6,txt:"Which of the following is a Type B (Bizarre) adverse drug reaction?",ref:"",opts:["Gastritis from Aspirin", "Bradycardia from Beta-blockers", "Anaphylaxis from Penicillin", "Dry mouth from Atropine"],ci:2,exp:"Type B reactions are idiosyncratic, unpredictable, and not related to the known pharmacological action of the drug."},{id:7,txt:"Post-marketing surveillance of a drug is part of which clinical trial phase?",ref:"",opts:["Phase II", "Phase 0", "Phase III", "Phase IV"],ci:3,exp:"Phase IV trials occur after a drug has been approved for the market to detect rare or long-term adverse effects."},{id:8,txt:"Which organ is the primary site for drug metabolism?",ref:"",opts:["Liver", "Spleen", "Lungs", "Kidney"],ci:0,exp:"The liver contains the microsomal enzyme systems (like Cytochrome P450) responsible for the biotransformation of most drugs."},{id:9,txt:"A drug that binds to a receptor and produces an effect opposite to that of an agonist is called:",ref:"",opts:["Partial agonist", "Antagonist", "Competitive inhibitor", "Inverse agonist"],ci:3,exp:"Inverse agonists bind to the same receptor as agonists but induce a pharmacological response opposite to that of the agonist."},{id:10,txt:"Which of the following describes the \'Volume of Distribution\' ($V_d$)?",ref:"",opts:["The time required for the drug concentration to reduce by half", "A ratio of the total amount of drug in the body to the plasma concentration", "The actual volume of blood in the body", "The rate at which the drug is cleared by the kidneys"],ci:1,exp:"$V_d$ is a theoretical volume that relates the amount of drug in the body to the concentration measured in the plasma."},{id:11,txt:"Which of the following is a Phase II metabolic reaction?",ref:"",opts:["Oxidation", "Reduction", "Hydrolysis", "Glucuronidation"],ci:3,exp:"Phase II reactions are conjugation reactions, such as glucuronidation, acetylation, and sulfation, which make the drug more polar for excretion."},{id:12,txt:"The therapeutic index of a drug is a measure of its:",ref:"",opts:["Bioavailability", "Potency", "Safety", "Efficacy"],ci:2,exp:"The Therapeutic Index is the ratio of the dose that produces toxicity to the dose that produces a clinically desired effect ($TI = \\frac{TD_{50}}{ED_{50}}$)."},{id:13,txt:"Which clinical trial phase is also known as \"Human Microdosing\" studies?",ref:"",opts:["Phase 0", "Phase I", "Phase III", "Phase II"],ci:0,exp:"Phase 0 trials involve the administration of very sub-therapeutic doses to humans to study pharmacokinetics before Phase I."},{id:14,txt:"An adverse drug reaction that occurs due to a genetic deficiency (e.g., hemolysis in G6PD deficiency) is termed:",ref:"",opts:["Side effect", "Allergy", "Idiosyncrasy", "Toxic effect"],ci:2,exp:"Idiosyncratic reactions are genetically determined abnormal responses to a drug that are unpredictable and not dose-related."},{id:15,txt:"Which of the following is an example of a \'Type C\' adverse drug reaction?",ref:"",opts:["Teratogenicity", "Carcinogenicity", "Tardive dyskinesia from long-term neuroleptics", "Anaphylactic shock"],ci:2,exp:"Type C (Continuous) reactions occur due to long-term drug use or cumulative dose effects."},{id:16,txt:"When two drugs with similar pharmacological actions produce an effect equal to the sum of their individual effects, it is called:",ref:"",opts:["Antagonism", "Synergism", "Additive effect", "Potentiation"],ci:2,exp:"In an additive effect, the combined effect of Drug A + Drug B equals the sum of $A + B$ (e.g., Aspirin + Paracetamol)."},{id:17,txt:"The \'First-order kinetics\' of drug elimination means:",ref:"",opts:["The rate of elimination is independent of plasma concentration", "The drug is eliminated entirely in the first hour", "A constant fraction of the drug is eliminated per unit time", "A constant amount of drug is eliminated per unit time"],ci:2,exp:"In first-order kinetics, the rate of elimination is directly proportional to the plasma concentration of the drug."},{id:18,txt:"Which phase of a clinical trial involves \"Single-blind\" or \"Double-blind\" designs to confirm efficacy in a large patient population (1000-3000)?",ref:"",opts:["Phase II", "Phase III", "Phase I", "Phase IV"],ci:1,exp:"Phase III trials are large-scale, multicenter trials designed to confirm efficacy and monitor adverse reactions in a broader population."},{id:19,txt:"Which organ is primarily responsible for the \'Excretion\' of water-soluble drugs?",ref:"",opts:["Skin", "Lungs", "Kidney", "Liver"],ci:2,exp:"The kidneys are the major organ for the excretion of drugs and their metabolites through glomerular filtration and tubular secretion."},{id:20,txt:"Which of the following describes the \'Affinity\' of a drug?",ref:"",opts:["The measure of the drug's safety margin", "The ability of a drug to produce a maximum response", "The ability of a drug to bind to its receptor", "The rate at which the drug is absorbed into the blood"],ci:2,exp:"Affinity refers to the tendency of a drug to bind to a specific receptor, while intrinsic activity refers to its ability to activate that receptor."},{id:21,txt:"Which route of drug administration is most likely to be affected by the \'First-pass effect\'?",ref:"",opts:["Oral", "Transdermal", "Sublingual", "Rectal"],ci:0,exp:"Drugs taken orally are absorbed from the GI tract and carried via the portal vein to the liver, where they may be metabolized before reaching systemic circulation."},{id:22,txt:"Teratogenicity refers to drug-induced damage occurring in:",ref:"",opts:["The fetus", "The liver", "The kidneys", "The elderly"],ci:0,exp:"Teratogenicity is the ability of a drug to cause structural or functional defects in a developing fetus when taken by a pregnant woman."},{id:23,txt:"In clinical trials, the \'Double-blind\' procedure is used to:",ref:"",opts:["Ensure the drug is 100% safe", "Speed up the drug approval process", "Reduce investigator and patient bias", "Reduce the cost of the trial"],ci:2,exp:"In a double-blind trial, neither the participant nor the researcher knows who is receiving the active drug or the placebo, minimizing subjective bias."},{id:24,txt:"Which of the following is a classic example of an \'Enzyme Inducer\'?",ref:"",opts:["Rifampin", "Erythromycin", "Cimetidine", "Ketoconazole"],ci:0,exp:"Rifampin increases the activity of hepatic microsomal enzymes, which can lead to decreased plasma levels of co-administered drugs like oral contraceptives."},{id:25,txt:"What does \'ED50\' stand for in pharmacodynamics?",ref:"",opts:["The dose that is lethal to 50% of subjects", "The dose that produces a therapeutic effect in 50% of the population", "The duration of action of 50mg of a drug", "The dose that is excreted in 50 minutes"],ci:1,exp:"$ED_{50}$ (Effective Dose 50) is the dose required to produce a specific intensity of effect in 50% of individuals."},{id:26,txt:"A Phase II clinical trial is typically performed on:",ref:"",opts:["Healthy human volunteers", "The entire population after the drug is released", "A small group of patients (100\u2013300) to assess efficacy", "Animals like rats and rabbits"],ci:2,exp:"Phase II trials are the first time the drug\'s effectiveness is tested in patients who actually have the disease the drug is intended to treat."},{id:27,txt:"Which of the following is a \'Type D\' adverse drug reaction?",ref:"",opts:["Rebound hypertension after stopping a drug", "Dry mouth from antidepressants", "Carcinogenicity appearing years after treatment", "Skin rash immediately after injection"],ci:2,exp:"Type D (Delayed) reactions are those that manifest a long time after the drug exposure, such as teratogenesis or carcinogenesis."},{id:28,txt:"The primary mechanism of drug transport across most biological membranes is:",ref:"",opts:["Simple diffusion", "Facilitated diffusion", "Pinocytosis", "Active transport"],ci:0,exp:"Most drugs are small, lipid-soluble molecules that cross cell membranes by simple passive diffusion along a concentration gradient."},{id:29,txt:"Which of the following terms describes the \'maximal response\' that can be elicited by a drug?",ref:"",opts:["Tolerance", "Potency", "Efficacy", "Bioavailability"],ci:2,exp:"Efficacy (or intrinsic activity) refers to the greatest effect ($E_{max}$) a drug can produce regardless of the dose."},{id:30,txt:"Which of the following describes the \'Steady State\' concentration of a drug?",ref:"",opts:["When the drug's half-life becomes zero", "When the drug reaches the brain", "When the rate of drug administration equals the rate of elimination", "When the drug is completely absorbed from the GI tract"],ci:2,exp:"Steady state is reached after approximately 4 to 5 half-lives, where the amount of drug entering the systemic circulation matches the amount being cleared."},{id:31,txt:"The \'Placebo\' effect in clinical trials is primarily related to:",ref:"",opts:["Psychological or non-specific effects of treatment", "Pharmacokinetic interactions", "The chemical properties of the drug", "Permanent changes in DNA"],ci:0,exp:"A placebo is an inert substance; the \'effect\' observed is due to the patient\'s expectation or the act of receiving medical care rather than a pharmacological action."},{id:32,txt:"Which of the following is an example of a \'Competitive Antagonist\'?",ref:"",opts:["Omeprazole", "Organophosphates", "Aspirin", "Propranolol"],ci:3,exp:"Propranolol competes with adrenaline for the same binding site on Beta-receptors; its effect can be overcome by increasing the concentration of the agonist."},{id:33,txt:"Which phase of a clinical trial involves testing the drug in a small group of patients (100â€“300) to find the \'Proof of Concept\'?",ref:"",opts:["Phase II", "Phase IV", "Phase I", "Phase III"],ci:0,exp:"Phase II is focused on establishing whether the drug actually works for the intended disease (efficacy) and determining the optimal dose range."},{id:34,txt:"The \'Therapeutic Window\' is the range of drug concentrations between:",ref:"",opts:["Absorption phase and elimination phase", "Minimum effective concentration and minimum toxic concentration", "Oral dose and intravenous dose", "Zero concentration and the peak plasma level"],ci:1,exp:"The therapeutic window represents the safety range where the drug provides clinical benefit without causing significant toxicity."},{id:35,txt:"Accumulation of a drug in the body is most likely to occur if:",ref:"",opts:["The dosing interval is shorter than the drug's half-life", "The drug is rapidly excreted by the kidneys", "The drug has a very high first-pass metabolism", "The drug is administered topically"],ci:0,exp:"If a second dose is given before the first dose is cleared, the plasma concentration will rise, leading to accumulation."},{id:36,txt:"Which of the following is a \'Type E\' (End-of-use) adverse drug reaction?",ref:"",opts:["Anaphylaxis from Penicillin", "Weight gain from steroids", "Sudden withdrawal syndrome after stopping Clonidine", "Liver damage from Paracetamol overdose"],ci:2,exp:"Type E reactions occur when a drug is suddenly discontinued, leading to withdrawal symptoms or a \'rebound\' of the original condition."},{id:37,txt:"Which regulatory body in India is responsible for approving new drugs and clinical trials?",ref:"",opts:["MHRA", "CDSCO", "FDA", "TGA"],ci:1,exp:"The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), is the national regulatory authority."},{id:38,txt:"Bioavailability is calculated by comparing the \'Area Under the Curve\' (AUC) of an oral dose to the AUC of:",ref:"",opts:["A subcutaneous dose", "A rectal dose", "An intramuscular dose", "An intravenous dose"],ci:3,exp:"Absolute bioavailability is measured by the ratio of $AUC_{oral} / AUC_{IV}$, as the IV route is considered to have 100% bioavailability."},{id:39,txt:"The term \'Pharmacognosy\' refers to the study of:",ref:"",opts:["Drugs derived from natural sources", "Synthetic drug manufacturing", "Mathematical models of drug action", "Drug pricing and marketing"],ci:0,exp:"Pharmacognosy is the branch of pharmacology that deals with medicinal drugs obtained from plants, animals, or other natural sources."},{id:40,txt:"Which of the following describes the \'Half-life\' ($t_{1/2}$) of a drug?",ref:"",opts:["The time taken for the drug to reach the site of action", "The time taken for the plasma concentration to reduce by 50%", "The total duration of the drug's action in the body", "The time required for the drug to be completely absorbed"],ci:1,exp:"Plasma half-life is the time it takes for the concentration of a drug in the blood to decline to half of its initial value."},{id:41,txt:"The \'Mechanism of Action\' of a drug (e.g., binding to a specific enzyme) is a part of:",ref:"",opts:["Pharmaceutics", "Pharmacogenetics", "Pharmacokinetics", "Pharmacodynamics"],ci:3,exp:"Pharmacodynamics is the study of the biochemical and physiological effects of drugs and their mechanisms of action (what the drug does to the body)."},{id:42,txt:"Which Phase of clinical trials is also known as the \'Therapeutic Confirmation\' phase?",ref:"",opts:["Phase III", "Phase I", "Phase II", "Phase IV"],ci:0,exp:"Phase III trials are designed to confirm the preliminary evidence gathered in Phase II that a drug is safe and effective in the intended patient population."},{id:43,txt:"The \'Gray Baby Syndrome\' caused by Chloramphenicol is due to the deficiency of which enzyme in neonates?",ref:"",opts:["Cytochrome P450", "Glucuronyl transferase", "Alcohol dehydrogenase", "MAO enzyme"],ci:1,exp:"Neonates have an immature liver and lack the glucuronyl transferase enzyme needed to metabolize Chloramphenicol, leading to toxic accumulation."},{id:44,txt:"Which of the following is a \'Type A\' (Augmented) adverse drug reaction?",ref:"",opts:["Anticoagulant-induced bleeding", "Vaccine-induced fever", "Penicillin-induced anaphylaxis", "Post-marketing surveillance"],ci:0,exp:"Type A reactions are dose-dependent and predictable based on the known pharmacology of the drug (e.g., thinning blood too much leads to bleeding)."},{id:45,txt:"What is the \'Bioavailability\' of a drug administered by the Intravenous (IV) route?",ref:"",opts:["75%", "100%", "50%", "0%"],ci:1,exp:"By definition, the IV route delivers the drug directly into the systemic circulation, bypassing all barriers to absorption and first-pass metabolism."},{id:46,txt:"An \'Informed Consent\' form must be signed by the participant before starting which process?",ref:"",opts:["Manufacturing a new batch of drugs", "Routine prescription of a generic drug", "Purchasing OTC medication", "Clinical trial participation"],ci:3,exp:"Informed consent is a mandatory ethical and legal requirement in clinical trials to ensure participants understand the risks and benefits."},{id:47,txt:"Which term describes a drug that binds to a receptor and produces a sub-maximal response even at high doses?",ref:"",opts:["Antagonist", "Full agonist", "Inverse agonist", "Partial agonist"],ci:3,exp:"A partial agonist has affinity for a receptor but possesses lower intrinsic activity compared to a full agonist."},{id:48,txt:"The study of \'Adverse Drug Reactions\' (ADR) and their monitoring in the general population is known as:",ref:"",opts:["Pharmacovigilance", "Pharmacokinetics", "Pharmacogenetics", "Pharmacotherapeutics"],ci:0,exp:"Pharmacovigilance is the science relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems."},{id:49,txt:"Which of the following is an example of an \'Enzyme Inhibitor\'?",ref:"",opts:["Carbamazepine", "Phenytoin", "Phenobarbitone", "Cimetidine"],ci:3,exp:"Cimetidine is a well-known enzyme inhibitor that decreases the metabolism of other drugs like Theophylline or Warfarin, potentially leading to toxicity."}],m:null,tt:1500,nm:0.25},
st={cq:0,a:Array(qd.q.length).fill(null),mk:Array(qd.q.length).fill(false),tr:qd.tt,ti:null,sb:false,rv:false,th:'light'};
document.addEventListener('DOMContentLoaded',()=>{sms();pcc();lt()});
function lt(){const t=localStorage.getItem('qt')||'light';st.th=t;document.documentElement.setAttribute('data-theme',t);uti()}
function tgt(){st.th=st.th==='light'?'dark':'light';document.documentElement.setAttribute('data-theme',st.th);localStorage.setItem('qt',st.th);uti()}
function uti(){const i=document.querySelector('#tt i');if(i)i.className=st.th==='light'?'fas fa-moon':'fas fa-sun'}
function pcc(){document.addEventListener('contextmenu',e=>e.preventDefault());document.addEventListener('copy',e=>e.preventDefault());document.addEventListener('cut',e=>e.preventDefault());document.addEventListener('selectstart',e=>{if(!e.target.tagName.match(/INPUT|TEXTAREA/i))e.preventDefault()})}
function sms(){const mc=document.querySelectorAll('.mode-card'),sb=document.getElementById('sb');mc.forEach(c=>{c.addEventListener('click',()=>{mc.forEach(x=>x.classList.remove('selected'));c.classList.add('selected');qd.m=c.dataset.mode;sb.disabled=false})});sb.addEventListener('click',sq)}
function sq(){const ct=document.getElementById('ct'),ctv=parseInt(ct.value);if(ctv&&ctv>0){st.tr=ctv*60;qd.tt=ctv*60}document.body.style.overflow='hidden';document.getElementById('modeSelection').style.display='none';document.getElementById('quizContainer').style.display='block';document.getElementById('mb').textContent=qd.m;document.getElementById('mb').className='mode-badge '+qd.m;iq()}
function iq(){rq(0);rqg();stt();sn()}
function stt(){utd();st.ti=setInterval(()=>{st.tr--;utd();if(st.tr<=0){clearInterval(st.ti);sbq()}if(st.tr<=60)document.getElementById('td').classList.add('warning')},1000)}
function utd(){const m=Math.floor(st.tr/60),s=st.tr%60;document.getElementById('tt2').textContent=`${String(m).padStart(2,'0')}:${String(s).padStart(2,'0')}`}
function rq(i){st.cq=i;const q=qd.q[i],qs=document.getElementById('qs');let h=`<div class="question-card"><div class="question-number"><i class="fas fa-question-circle"></i>Question ${i+1} of ${qd.q.length}</div>`;if(q.ref)h+=`<div class="question-reference protected-content"><i class="fas fa-info-circle"></i> ${q.ref}</div>`;h+=`<div class="question-text protected-content">${q.txt}</div><div class="options-container">`;q.opts.forEach((o,x)=>{let bc='option-btn',ic=String.fromCharCode(65+x);const isSel=st.a[i]===x,isCor=x===q.ci,shAns=(qd.m==='practice'&&st.a[i]!==null)||st.sb;if(isSel)bc+=' selected';if(shAns){bc+=' disabled';if(isCor){bc+=' correct';ic='<i class="fas fa-check"></i>'}else if(isSel&&!isCor){bc+=' incorrect';ic='<i class="fas fa-times"></i>'}}h+=`<button class="${bc}" data-index="${x}" onclick="so(${x})"><div class="option-indicator">${ic}</div><div class="option-text protected-content">${o}</div></button>`});h+=`</div>`;const shExp=(qd.m==='practice'&&st.a[i]!==null)||st.sb;if(shExp)h+=`<div class="explanation-box" style="display:block"><div class="explanation-header"><i class="fas fa-lightbulb"></i>Explanation</div><div class="explanation-text protected-content">${q.exp}</div></div>`;h+=`</div>`;qs.innerHTML=h;qs.scrollTop=0;up();unb();uqg()}
function so(oi){if(st.sb)return;if(st.a[st.cq]===oi){st.a[st.cq]=null}else{st.a[st.cq]=oi}rq(st.cq)}
function sn(){document.getElementById('pv').addEventListener('click',np);document.getElementById('nx').addEventListener('click',nn);document.getElementById('mk').addEventListener('click',tm);document.getElementById('sm').addEventListener('click',cs);document.getElementById('nt').addEventListener('click',tnp);document.getElementById('nc').addEventListener('click',tnp);document.getElementById('rb').addEventListener('click',ra);document.getElementById('rsb').addEventListener('click',rs);document.getElementById('tt').addEventListener('click',tgt);document.addEventListener('keydown',e=>{if(st.sb)return;if(e.key==='ArrowLeft')np();if(e.key==='ArrowRight')nn()})}
function np(){if(st.cq>0)rq(st.cq-1)}
function nn(){if(st.cq<qd.q.length-1)rq(st.cq+1)}
function tm(){st.mk[st.cq]=!st.mk[st.cq];uqg();const mb=document.getElementById('mk');mb.innerHTML=st.mk[st.cq]?'<i class="fas fa-bookmark"></i> Unmark':'<i class="fas fa-bookmark"></i> Mark'}
function unb(){document.getElementById('pv').disabled=st.cq===0;if(st.cq===qd.q.length-1){document.getElementById('nx').style.display='none';document.getElementById('sm').style.display='flex'}else{document.getElementById('nx').style.display='flex';document.getElementById('sm').style.display='none'}const mb=document.getElementById('mk');mb.innerHTML=st.mk[st.cq]?'<i class="fas fa-bookmark"></i> Unmark':'<i class="fas fa-bookmark"></i> Mark'}
function up(){const at=st.a.filter(a=>a!==null).length,pr=((st.cq+1)/qd.q.length)*100;document.getElementById('pt').textContent=`Question ${st.cq+1} of ${qd.q.length}`;document.getElementById('at').textContent=`Attempted: ${at}/${qd.q.length}`;document.getElementById('pb').style.width=pr+'%'}
function rqg(){const g=document.getElementById('qg');g.innerHTML='';qd.q.forEach((_,i)=>{const it=document.createElement('div');it.className='question-nav-item';it.textContent=i+1;it.onclick=()=>{rq(i);if(window.innerWidth<768)tnp()};g.appendChild(it)})}
function uqg() {
    const its = document.querySelectorAll('.question-nav-item');
    its.forEach((it, i) => {
        it.className = 'question-nav-item';
        if (i === st.cq) it.classList.add('current');
        if (st.sb) {
            if (st.a[i] === qd.q[i].ci) it.classList.add('correct');
            else if (st.a[i] !== null) it.classList.add('incorrect');
        } else {
            if (st.a[i] !== null) it.classList.add('answered');
            if (st.mk[i]) it.classList.add('marked');
        }
    });
}
function tnp(){document.getElementById('np').classList.toggle('open')}
function cs(){const u=st.a.filter(a=>a===null).length;if(u>0){const c=window.confirm(`You have ${u} unattempted question(s). Do you want to submit?`);if(!c)return}sbq()}
function sbq(){clearInterval(st.ti);st.sb=true;let c=0,ic=0,u=0,nm=0;st.a.forEach((a,i)=>{if(a===null)u++;else if(a===qd.q[i].ci)c++;else{ic++;nm+=qd.nm}});const ts=c-nm,pc=(ts/qd.q.length)*100;document.body.style.overflow='auto';document.getElementById('quizContainer').style.display='none';document.getElementById('resultsContainer').style.display='block';document.getElementById('resultsContainer').classList.add('scrollable');if(pc>=70){document.getElementById('ri').innerHTML='<i class="fas fa-trophy" style="color:#fbbf24"></i>';document.getElementById('rt').textContent='Excellent Performance!'}else if(pc>=50){document.getElementById('ri').innerHTML='<i class="far fa-smile" style="color:#48bb78"></i>';document.getElementById('rt').textContent='Good Job!'}else{document.getElementById('ri').innerHTML='<i class="far fa-meh" style="color:#f5576c"></i>';document.getElementById('rt').textContent='Keep Practicing!'}document.getElementById('rs').textContent=ts.toFixed(2)+' / '+qd.q.length;document.getElementById('rp').textContent=pc.toFixed(1)+'%';document.getElementById('cc').textContent=c;document.getElementById('ic').textContent=ic;document.getElementById('uc').textContent=u;document.getElementById('nm').textContent='-'+nm.toFixed(2)}
function ra(){st.rv=true;document.body.style.overflow='hidden';document.getElementById('resultsContainer').style.display='none';document.getElementById('quizContainer').style.display='block';rq(0);uqg()}
function rs(){document.body.style.overflow='hidden';location.reload()}
</script>
</body>
</html>